HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply ot the article "Continuously infused carboplatin used as radiosensitizer in locally unresectable no-small-cell lung cancer: a multicenter phase III study", by Groen et al. (Ann Oncol 2004; 15: 427-432).

AuthorsB Jeremic
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 15 Issue 8 Pg. 1298-9 (Aug 2004) ISSN: 0923-7534 [Print] England
PMID15386828 (Publication Type: Comment, Letter)
Chemical References
  • Antineoplastic Agents
  • Radiation-Sensitizing Agents
  • Carboplatin
Topics
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Carboplatin (administration & dosage)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, radiotherapy)
  • Combined Modality Therapy
  • Disease-Free Survival
  • Evidence-Based Medicine
  • Humans
  • Lung Neoplasms (drug therapy, radiotherapy)
  • Multivariate Analysis
  • Radiation-Sensitizing Agents (administration & dosage)
  • Reproducibility of Results
  • Research Design

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: